M&A Deal Summary |
|
|---|---|
| Date | 2024-03-06 |
| Target | Groupe ADF |
| Sector | Engineering |
| Buyer(s) |
Andera Partners
Siparex |
| Sellers(s) | Abénex |
| Deal Type | Secondary Buyout |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 3.7B EUR |
| Size | Large |
| Type | Sector Agnostic |
Andera Partners is a private investment firm focused on several strategies. The Firm invests in life science opportunities through its BioDiscovery group. The Firm invests in Western European small to mid-sized companies (€30 to €300 million of revenue) through its Winch Capital group. Andera invests in small to mid-sized French companies (€10 to €100 million of revenue) through its Cabestan Capital team. Andera invests in €5 to €45 million of mezzanine capital to support small to mid-sized French companies. Andera Partners was established in 2001 and is headquartered in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 106 of 106 |
| Sector: Engineering M&A | 2 of 2 |
| Type: Secondary Buyout M&A Deals | 14 of 14 |
| Country: France M&A | 70 of 70 |
| Year: 2024 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-01-29 |
Meotec
Boulogne-Billancourt, France Meotec is a consulting firm specializing in project and purchasing management. More than 300 consultants support customers in five different skills: project management, procurement, economic performance, quality and processes, and interim management. Meotec was founded in 2005 and is based in Boulogne-Billancourt, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-03-14 |
Amolyt Pharma
Ecully, France Amolyt Pharma is a clinical-stage biotechnology company, building therapeutic peptides to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma was founded in 2015 and is based in Ecully, France. |
Sell | $1.1B |
| Category | Private Equity Firm |
|---|---|
| Founded | 1977 |
| PE ASSETS | 4.0B EUR |
| Size | Large |
| Type | Sector Agnostic |
Siparex is a French private equity firm that looks to invest mezzanine or equity capital in companies at all stages of development. The Firm separates its investment activity into mid-market, mezzanine, and small-cap. Within mid-market, Siparex looks to invest €2.5 to €40 million in companies with at least €15 million in sales. Prospective transaction situations include buyouts, shareholder liquidity events, and growth capital financings. The Firm will consider all business sectors. Within its mezzanine group, Siparex looks to invest €2 to €10 million to support growth, acquisitions, refinancings, and restructurings. The small-cap group seeks investments starting at €300K in early-stage companies as well as those undergoing expansion or being sold. Siparex was formed in 1977 and is based in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 90 of 102 |
| Sector: Engineering M&A | 3 of 3 |
| Type: Secondary Buyout M&A Deals | 16 of 18 |
| Country: France M&A | 83 of 95 |
| Year: 2024 M&A | 3 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-03-04 |
Rumeur Publique
Saint-Denis, France Rumeur Publique is an independent communications agency specialising in corporate and institutional influence consulting. Rumeur Publique provides services such as brand strategy, media relations, public affairs and digital content for clients across technology, industry, energy, transport and finance sectors. Rumeur Publique was founded in 1988 and is based in Saint-Denis, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-04-12 |
Capron Podologie
Ecuisses, France Capron Podologie supplies professional equipment, materials, and instruments for podiatry and pedicure practices. The Company provides diagnostic tools, care units, sterilization systems, consumables, and fabrication materials used by healthcare practitioners and laboratories. Capron Podologie was founded in 1974 and is based in Ecuisses, France. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1992 |
| PE ASSETS | 1.5B EUR |
| Size | Large |
| Type | Sector Agnostic |
Abénex Capital SA is a French private equity firm focuses on acquiring mid-market companies throughout France. The Firm seeks to hold both majority and minority equity interest in companies along with the management teams. Specific areas of interest include consumer productsinterests, business services, industry and healthcare sector. The Firm will consider variety of transaction includes MBOs, MBIs, and LBO. Abénex, Capital SA was formerly known as ABN Amro Capital France and became independent of ABN Amro in 2008. Abénex Capital SA is based in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 22 of 23 |
| Sector: Engineering M&A | 1 of 1 |
| Type: Secondary Buyout M&A Deals | 12 of 12 |
| Country: France M&A | 21 of 22 |
| Year: 2024 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-07-05 |
Prevost Laboratory Concept
Nouvoitou, France Prevost Laboratory Concept specializes in the formulation and manufacturing of cosmetics, food supplements, and animal care products. Prevost Laboratory Concept provides a complete service to its customers by formulating, producing, and packaging capacities. Prevost Laboratory Concept adapts to all batch sizes, provides a wide variety of packaging, and offers numerous galenic forms. Prevost Laboratory Concept was founded in 1992 and is based in Nouvoitou, France. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-01-22 |
Emeraude Capital
Quimper, France Emeraude Capital’s offer is built around four key areas of expertise – insurance intermediation, financial investment advice, wealth engineering and social protection. Emeraude Capital was formed in 2024 and is based in Quimper, France. |
Buy | - |
